New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.

Researchers suggest tunneling may reflect a conserved strategy adopted by specialized migratory cell types in dense tissues.

The customizable platform used AAVs to deliver genetic cargo that induced the production of three anti-inflammatory cytokines ...

This eBook brings together a curated collection of resources to help you break through the constraints of throughput, ...

Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

Minimal residual disease (MRD) continues to be a central focus at the AACR meeting. The small numbers of cancer cells that ...

In this virtual summit GEN invites you to watch a superb line-up of presenters covering key topics in the world of multiomics, spatial biology, and NGS.

AACR chairs Paul Mischel and Alice Shaw shared insights with GEN on the key themes shaping this year’s program.

Daraxonrasib improved survival in metastatic pancreatic cancer in Phase III, signaling meaningful progress for therapies targeting RAS‑driven disease.

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.

An iPSC manufacturing strategy for cell therapies drops the cost of goods sold to about $5,000 per dose, down from $115,000 per dose for autologous therapeutics and $40,000 per dose for allogeneic ...